Fixed dose pharmaceutical compositions for treating overactive bladder and related conditions
WO2017210700A1
Compositions and methods of using modified release solabegron for lower urinary tract symptoms
EP3463312A1
Dosing regimens for beta-3 adrenoceptor agonists and anti-muscarinic agents for the treatment and prevention of lower urinary tract symptoms and overactive bladder
US2017151199A1
Pharmaceutical compositions and the treatment of overactive bladder
WO2017070689A2
Solabegron zwitterion and uses thereof
US2016158176A1
Compositions and methods of using modified release solabegron for lower urinary tract symptoms
